Evidence map›Paper›PMID 41545595›Full record

ArticleNature medicine2026

Single-cell atlas of the developing Down syndrome brain cortex.

Michael Lattke, Wee Leng Tan, Salil Kalarikkal Sukumaran, Kagistia Hana Utami, Marcos Sintes, Srinivasan Sakthivel, Jonathan Tan, Auriel Lim, Vibhavari Aysha Bansal, Katerina Rekopoulou and 6 more

Abstract read
In one paragraph

Article in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. From a developmental atlas to maps of disease origin.Clinical and translational medicine · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Michael LattkeDepartment of Brain Sciences, Imperial College London, London, UK. m.lattke@imperial.ac.uk.ORCID http://orcid.org/0000-0001-5533-8592
Wee Leng TanDuke-NUS Medical School, Singapore, Singapore.ORCID http://orcid.org/0009-0007-4977-8656
Salil Kalarikkal SukumaranDuke-NUS Medical School, Singapore, Singapore.
Kagistia Hana UtamiDuke-NUS Medical School, Singapore, Singapore.
Marcos SintesDepartment of Brain Sciences, Imperial College London, London, UK.
Srinivasan SakthivelDuke-NUS Medical School, Singapore, Singapore.
Jonathan TanDuke-NUS Medical School, Singapore, Singapore.ORCID http://orcid.org/0009-0005-5105-7853
Auriel LimDuke-NUS Medical School, Singapore, Singapore.
Vibhavari Aysha BansalDuke-NUS Medical School, Singapore, Singapore.ORCID http://orcid.org/0000-0002-9745-3633
Katerina RekopoulouNIHR Imperial BRC Genomics Facility, Imperial College London, London, UK.
Nik MatthewsNIHR Imperial BRC Genomics Facility, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-0602-1131
Ivan AlićThe Blizard Institute, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0002-8125-8198
Željka KrsnikCroatian Institute for Brain Research, School of Medicine, University of Zagreb, Zagreb, Croatia.
Dean NižetićThe Blizard Institute, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0001-5486-5761
Boaz P LeviAllen Institute for Brain Science, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-8346-872X
Vincenzo De PaolaDepartment of Brain Sciences, Imperial College London, London, UK. videpa@nus.edu.sg.ORCID http://orcid.org/0000-0001-9987-8291

Funding

Hrvatska Zaklada za Znanost (Croatian Science Foundation) HRZZ-IP-2022-10-5975RCUK | Medical Research Council (MRC) MR/V034529/1Wellcome TrustWellcome Trust (Wellcome) 217199/Z/19/Z
6 · The paper itself

Abstract

Down syndrome (DS), caused by trisomy of chromosome 21, is the leading genetic cause of intellectual disability, yet the mechanisms disrupting fetal brain development remain unclear. We performed single-cell transcriptomic and chromatin accessibility profiling of approximately 250,000 cells from 15 DS and 15 control human fetal cortices (10-20 weeks postconception). Our analysis revealed a subtype-specific reduction in RORB- and FOXP1-expressing excitatory neurons and widespread disruption of neurodevelopmental transcriptional programs. Chromosome 21 transcription factors BACH1, PKNOX1 and GABPA emerged as dosage-sensitive hubs regulating genes linked to intellectual disability. Antisense oligonucleotide-mediated normalization of these transcription factors in human neural progenitors in vitro partially rescued target gene expression. Benchmarking a humanized in vivo model captured additional molecular and cellular signatures of DS, complementing the in vitro model. Together, we present a resource defining the gene-regulatory landscape underlying cortical development in DS and highlight molecular pathways for further investigation.

Indexed as

Cerebral CortexDown SyndromeAnimalsFemaleGene Expression Regulation, DevelopmentalHumansNeural Stem CellsNeurodevelopmentNeuronsSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisTranscription FactorsTranscriptomeTranscription Factors

Identifiers

PMID41545595
PMCPMC13004680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.